Unicycive Therapeutics (UNCY) Earnings Date & Reports
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
UNCY is expected to report earnings to fall 140.00% to -10 cents per share on May 20
Q1'25
Est.
$-0.10
Q4'24
Beat
by $0.34
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.09
Q1'24
Missed
by $0.82
The last earnings report on March 31 showed earnings per share of 25 cents, beating the estimate of -9 cents. With 879.67K shares outstanding, the current market capitalization sits at 65.55M.